6UC-26820-84370
3 vaccinations
4 coded responses
4 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 928 / CA
- Registered
- 2021-03-07
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-30
Dose 1 — Pfizer-BioNTech
-
2021-03-07
Registered in v-safe
-
2021-03-07
Dose 2 — Pfizer-BioNTech
-
2022-01-13
Dose 3 — Pfizer-BioNTech
-
2022-03-07
Survey response — 12 months, dose 2MedDRA: Chest pain, Dyspnoea, Fatigue, Headache, Oedema, Somnolence — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Very fatigue most of the time, headaches, short of breath frequent, chest pain upon exertion, edema, just want sleep.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-14
Survey response — 3 months, dose 3MedDRA: Dyspnoea exertional, Fatigue, Wheezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Short of breath upon minimal exertion. I never had this before. Fatigue/ my employer wrote me up for level due to oversleeping. I never had these problems before. They requested something that backups my symptoms. At night a whistling my chest helpMedDRA releases: 2024-11 · check-in free text available
-
2022-07-16
Survey response — 6 months, dose 3MedDRA: Dyspnoea, Fatigue, Somnolence, Vision blurred, Visual impairment — Feeling: PoorFree text: Feeling exhausted, very sleepy. Continue with shortness of breath, vision issues, sometimes blurry that need to readjusted to focusMedDRA releases: 2024-11 · check-in free text available
-
2023-01-13
Survey response — 12 months, dose 3MedDRA: COVID-19, Cold sweat, Cough, Decreased appetite, Fatigue, Nasal congestion, Pain, Pyrexia — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-03-07 | Pfizer-BioNTech | |
| 3 | 2022-01-13 | Pfizer-BioNTech | No |
Free text
Release 11 — 12 months, dose 2
Symptoms: Very fatigue most of the time, headaches, short of breath frequent, chest pain upon exertion, edema, just want sleep.
Release 11 — 3 months, dose 3
Symptoms: Short of breath upon minimal exertion. I never had this before. Fatigue/ my employer wrote me up for level due to oversleeping. I never had these problems before. They requested something that backups my symptoms. At night a whistling my chest help cut off by CDC
Release 12 — 6 months, dose 3
Symptoms: Feeling exhausted, very sleepy. Continue with shortness of breath, vision issues, sometimes blurry that need to readjusted to focus
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest pain | · | · | ✓ |
| SD | Cold sweat | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Dyspnoea exertional | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oedema | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Somnolence | · | · | ✓ |
| SD | Vision blurred | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release